One study showed that 5′-tiRNAVal, as a new tumor suppressor, can directly target the 3′-UTR sequence in frizzled class receptor 3 (FZD3) and inhibit the FZD3-mediated Wnt/β-catenin signaling pathway in BC cells [82]. The gene discussed is FZD3; the disease is breast cancer.